DECIPHERA PHARMACEUTICALS, LLC
Patent Owner
Stats
- 21 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jul 27, 2017 most recent publication
Details
- 21 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,046 Total Citation Count
- Dec 24, 2003 Earliest Filing
- 31 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0209,428 METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCERAug 31, 16Jul 27, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9457019 Methods for inhibiting tie-2 kinase useful in the treatment of cancerNov 07, 14Oct 04, 16[A61K, C07D, C07K]
9387202 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesNov 20, 14Jul 12, 16[A61K, C07D]
9382228 N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Jul 05, 16[C07D]
9309224 N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Apr 12, 16[C07D]
9193719 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Nov 24, 15[A61K, C07D]
9181223 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Nov 10, 15[A61K, C07D]
9133183 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Sep 15, 15[A61K, C07D]
9012635 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesMar 14, 14Apr 21, 15[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0101,090 INHIBITION OF TRK KINASE MEDIATED TUMOR GROWTH AND DISEASE PROGRESSIONAbandonedOct 14, 15Apr 14, 16[A61K]
2015/0320,759 DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASESAbandonedDec 04, 14Nov 12, 15[A61K]
2015/0218,130 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESAbandonedJan 22, 15Aug 06, 15[C07D]
2014/0194,405 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESAbandonedDec 20, 13Jul 10, 14[C07D]
8486951 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activitiesExpiredAug 21, 12Jul 16, 13[A01N, C07D]
2012/0289,540 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASESAbandonedApr 12, 12Nov 15, 12[A61K, A61P]
2012/0252,849 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESAbandonedMay 24, 12Oct 04, 12[A61K, C07D, A61P]
2012/0225,057 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASESAbandonedSep 08, 11Sep 06, 12[A61K, C12N, A61P]
8143293 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseasesExpiredApr 18, 08Mar 27, 12[A61K, C07D]
2012/0058,985 CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIESAbandonedApr 29, 11Mar 08, 12[A61K, C07D, A61P]
2011/0189,167 Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative DiseasesAbandonedAug 04, 10Aug 04, 11[A61K, A61P]
7897762 Kinase inhibitors useful for the treatment of proliferative diseasesExpiredSep 12, 07Mar 01, 11[A61K, C07D]
2008/0269,254 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFIC DISEASES AND OTHER PROLIFERATIVE DISEASESAbandonedApr 18, 08Oct 30, 08[A61K, C07D, A61P]
2008/0269,267 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFIC DISEASES AND OTHER PROLIFERATIVE DISEASESAbandonedApr 18, 08Oct 30, 08[A61K, C07D, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.